Teva survives Copaxone patent challenge

22-05-2015

Teva has successfully defended two patents related to its blockbuster multiple sclerosis drug Copaxone (glatiramer acetate) at the English High Court.


Teva, Copaxone, Synthon, patent, High Court

LSIPR